BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33753859)

  • 1. Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.
    Kubiliute R; Januskeviciene I; Urbanaviciute R; Daniunaite K; Drobniene M; Ostapenko V; Daugelavicius R; Jarmalaite S
    Sci Rep; 2021 Mar; 11(1):6556. PubMed ID: 33753859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular features of doxorubicin-resistance development in colorectal cancer CX-1 cell line.
    Kubiliūtė R; Šulskytė I; Daniūnaitė K; Daugelavičius R; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(5):298-306. PubMed ID: 27746118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of the ABCB1 downstream gene promoter accompanies ABCB1 gene amplification and increased expression in docetaxel-resistant MCF-7 breast tumor cells.
    Reed K; Hembruff SL; Laberge ML; Villeneuve DJ; Côté GB; Parissenti AM
    Epigenetics; 2008 Sep; 3(5):270-80. PubMed ID: 19001875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
    Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
    J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of ATP-binding cassette subfamily B member 1 by Snail contributes to chemoresistance in colorectal cancer.
    Wang H; Li JM; Wei W; Yang R; Chen D; Ma XD; Jiang GM; Wang BL
    Cancer Sci; 2020 Jan; 111(1):84-97. PubMed ID: 31774615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
    Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
    Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic aberrations of ABCB1 synergistically boost the acquisition of taxane resistance in esophageal squamous cancer cells.
    Sumarpo A; Ito K; Saiki Y; Ishizawa K; Wang R; Chen N; Sunamura M; Horii A
    Biochem Biophys Res Commun; 2020 Jun; 526(3):586-591. PubMed ID: 32247608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation patterns of ABCB1, ABCC1 and ABCG2 in human cancer cell lines, multidrug-resistant cell models and tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.
    Spitzwieser M; Pirker C; Koblmüller B; Pfeiler G; Hacker S; Berger W; Heffeter P; Cichna-Markl M
    Oncotarget; 2016 Nov; 7(45):73347-73369. PubMed ID: 27689338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 6 regulated expression of IL-8 is involved in the doxorubicin (Dox) resistance of osteosarcoma cells via modulating ABCB1 transcription.
    Cheng M; Cai W; Huang W; Chen Y; Wu Z; Luo P; Yan W
    Eur J Pharmacol; 2018 Dec; 840():1-8. PubMed ID: 30273544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
    Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
    Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
    Sugano T; Seike M; Noro R; Soeno C; Chiba M; Zou F; Nakamichi S; Nishijima N; Matsumoto M; Miyanaga A; Kubota K; Gemma A
    Mol Cancer Ther; 2015 Nov; 14(11):2433-40. PubMed ID: 26351321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells.
    Hui RC; Francis RE; Guest SK; Costa JR; Gomes AR; Myatt SS; Brosens JJ; Lam EW
    Mol Cancer Ther; 2008 Mar; 7(3):670-8. PubMed ID: 18347152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-8 regulates the doxorubicin resistance of colorectal cancer cells via modulation of multidrug resistance 1 (MDR1).
    Du J; He Y; Li P; Wu W; Chen Y; Ruan H
    Cancer Chemother Pharmacol; 2018 Jun; 81(6):1111-1119. PubMed ID: 29693201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of poised oncogenes by ZMYND8 promotes chemo-sensitization.
    Mukherjee S; Adhikary S; Gadad SS; Mondal P; Sen S; Choudhari R; Singh V; Adhikari S; Mandal P; Chaudhuri S; Sengupta A; Lakshmanaswamy R; Chakrabarti P; Roy S; Das C
    Cell Death Dis; 2020 Dec; 11(12):1073. PubMed ID: 33323928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
    Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of ABCB1, β tubulin I, and III with multidrug resistance of MCF7/DOC subline from breast cancer cell line MCF7.
    Li W; Zhai B; Zhi H; Li Y; Jia L; Ding C; Zhang B; You W
    Tumour Biol; 2014 Sep; 35(9):8883-91. PubMed ID: 24894670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
    Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R
    PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase 2 regulates the doxorubicin (Dox) resistance of hepatocarcinoma cells and transcription of ABCB1.
    Yang Y; Zhang J; Wu T; Xu X; Cao G; Li H; Chen X
    Life Sci; 2019 Jan; 216():200-206. PubMed ID: 30465789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceritinib Enhances the Efficacy of Substrate Chemotherapeutic Agent in Human ABCB1-Overexpressing Leukemia Cells In Vitro, In Vivo and Ex-Vivo.
    Yang L; Li M; Wang F; Zhen C; Luo M; Fang X; Zhang H; Zhang J; Li Q; Fu L
    Cell Physiol Biochem; 2018; 46(6):2487-2499. PubMed ID: 29742496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.